^
Chr t(15;17)
Acute Promyelocytic Leukemia
arsenic trioxide
Sensitive
:
A1
PML-RARA fusion
Acute Promyelocytic Leukemia
arsenic trioxide
Sensitive
:
A1
No biomarker
Acute Promyelocytic Leukemia
gemtuzumab ozogamicin
Sensitive
:
A2
No biomarker
Acute Promyelocytic Leukemia
cytarabine + daunorubicin
Sensitive
:
A2
PML-RARA fusion
Acute Promyelocytic Leukemia
tretinoin + arsenic trioxide
Sensitive
:
C3
STAT5b-RARA fusion
Acute Promyelocytic Leukemia
DCAG
Sensitive
:
C4
PML-RARA fusion
Acute Promyelocytic Leukemia
cytarabine + idarubicin hydrochloride + tretinoin
Sensitive
:
C4
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression
Acute Promyelocytic Leukemia
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive
:
C4
PML-RARA T285I
Acute Promyelocytic Leukemia
venetoclax
Sensitive
:
C4
ZBTB16-RARA fusion
Acute Promyelocytic Leukemia
chidamide
Sensitive
:
D
STAT5b-RARA fusion
Acute Promyelocytic Leukemia
chidamide
Sensitive
:
D
NPM-RARA fusion
Acute Promyelocytic Leukemia
chidamide
Sensitive
:
D